Eledon Pharmaceuticals, Inc. (ELDN)
1.97
+0.06
(+3.14%)
USD |
NASDAQ |
Jan 13, 16:00
1.97
0.00 (0.00%)
After-Hours: 20:00
Eledon Pharmaceuticals EPS Diluted (Quarterly): -0.2263 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -0.3128 |
| Viking Therapeutics, Inc. | -0.8083 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.46M |
| Total Expenses (Quarterly) | 17.46M |
| Enterprise Value | 110.83M |
| Earnings Yield | -61.02% |
| Normalized Earnings Yield | -59.14 |